Clinox
ClinOx offers clients knowledge and expertise in the development, placement, conduct and analysis of early phase oncology clinical trials, with particular emphasis on pharmacokinetic and mechanistic endpoints.
ClinOx is based in Oxford and working with national and international research networks, and centres of scientific excellence with clinical expertise to provide an extraordinary opportunity for both pharmaceutical companies and biotechnology firms to:
* fast-track novel anti-cancer, therapeutic and diagnostic strategies
*test their kpromis in mechanistic clinical trials and
*enable them to make critical decisions on their durg portfolio at an earcly stage.
ClinOx is uniquely positioned to respond to the challenges posed by the new era of molecular targeted therapies, including the identification of patient subsets based on the biological or genetic expression of their tumour